Related Experiment Videos
Large-scale SNP scoring from unamplified genomic DNA
L Fors1, K W Lieder, S H Vavra
1Third Wave Technologies Inc, Madison, WI 53719, USA. lfors@twt.com
Pharmacogenomics
|March 21, 2001
Summary
The Invader assay provides a rapid, cost-effective method for high-throughput screening of single nucleotide polymorphisms (SNPs). This genetic testing approach enables accurate disease diagnostics using unamplified DNA.
Area of Science:
- Biotechnology
- Genomics
- Molecular Diagnostics
Background:
- The Human Genome Project (HGP) drives advancements in medical technology, increasing demand for genetic tests.
- Identifying single nucleotide polymorphisms (SNPs) linked to diseases necessitates efficient high-throughput screening (HTS) methods.
- Current SNP detection methods require improvement in cost-effectiveness, reliability, and throughput.
Purpose of the Study:
- To introduce and evaluate the Invader assay as a novel platform for SNP detection.
- To demonstrate the assay's capability for high-throughput, cost-effective genetic screening.
- To highlight the potential of the Invader assay in clinical diagnostics.
Main Methods:
- Utilizes a structure-specific 5' nuclease (flap endonuclease) for cleaving specific DNA structures.
- Employs two cascading reactions involving synthetic oligonucleotide probes and a FRET probe.
- Performs detection directly from unamplified genomic DNA without prior amplification.
Main Results:
- The Invader assay achieves high specificity and sensitivity in detecting single nucleotide changes.
- Significant signal amplification (over 10^6 cleaved probes per target molecule per hour) allows direct detection.
- Assay components for the secondary reaction are universal, adaptable to various targets.
Conclusions:
- The Invader assay is a simple, automatable, and cost-effective diagnostic platform for SNP scoring.
- Its high-throughput capability addresses the growing need for genetic testing in clinical laboratories.
- The technology facilitates direct detection of genetic variations from genomic DNA, streamlining diagnostics.